Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

<p>Abstract</p> <p>The matrix protein osteopontin has been shown to be a marker of osteoclastic activity in multiple myeloma patients, as well as a regulator of angiogenesis. We measured serum levels of osteopontin in 50 untreated multiple myeloma patients (in 25, also after treatm...

Full description

Bibliographic Details
Main Authors: Kotsis Vasileios, Alegakis Athanasios, Tsirakis George, Pappa Constantina, Miyakis Spiros, Sfiridaki Aikaterini, Stathopoulos Efstathios, Alexandrakis Michael
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Journal of Hematology & Oncology
Online Access:http://www.jhoonline.org/content/4/1/22